Case Report
Published on 10 Nov 2022
Primary pulmonary T-cell lymphoma after operation for small intestinal stromal tumor: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.926121
- 2,134 views
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,930 articles
articles
Systematic Review
Published on 10 Nov 2022
Effect of histology on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.968517
- 3,834 views
- 15 citations
Original Research
Published on 09 Nov 2022
PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.909721
- 4,347 views
- 7 citations
Mini Review
Published on 09 Nov 2022
Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.978608
- 2,813 views
- 5 citations
Original Research
Published on 09 Nov 2022
Machine learning identifies characteristics molecules of cancer associated fibroblasts significantly correlated with the prognosis, immunotherapy response and immune microenvironment in lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1059253
- 3,003 views
- 7 citations
Original Research
Published on 08 Nov 2022
Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.999606
- 2,610 views
- 4 citations
Original Research
Published on 08 Nov 2022
Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.972972
- 3,742 views
- 5 citations
Case Report
Published on 07 Nov 2022
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1038774
- 4,277 views
- 8 citations
Case Report
Published on 07 Nov 2022
Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.985446
- 2,345 views
- 6 citations
Systematic Review
Published on 03 Nov 2022
Efficacy and safety of brigatinib in ALK-positive non-small cell lung cancer treatment: A systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.920709
- 6,245 views
- 8 citations
Case Report
Published on 02 Nov 2022
Lung adenocarcinoma concurrent with congenital pulmonary aplasia of the right upper lobe: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.959502
- 1,800 views
Original Research
Published on 02 Nov 2022
Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.988332
- 2,935 views
- 5 citations
Case Report
Published on 01 Nov 2022
Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1020875
- 4,987 views
- 29 citations
Original Research
Published on 01 Nov 2022
Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.986367
- 3,632 views
- 11 citations
Original Research
Published on 01 Nov 2022
A prognostic signature model for unveiling tumor progression in lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1019442
- 3,795 views
- 5 citations
Brief Research Report
Published on 31 Oct 2022
Thymic cyst: Is attenuation artifactually increased on contrast-enhanced CT?
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.984770
- 1,647 views
- 1 citation
Original Research
Published on 31 Oct 2022
Single ultrasound-guided thoracic paravertebral block with a large volume of anesthetic for microwave ablation of lung tumors
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.955778
- 2,741 views
- 4 citations
Mini Review
Published on 28 Oct 2022
The sternum reconstruction: Present and future perspectives
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.975603
- 10,369 views
- 8 citations
Original Research
Published on 28 Oct 2022
Automated 3D segmentation of the aorta and pulmonary artery for predicting outcomes after thoracoscopic lobectomy in lung cancer patients
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1027036
- 2,681 views
Original Research
Published on 27 Oct 2022
DNA methylation topology differentiates between normal and malignant in cell models, resected human tissues, and exfoliated sputum cells of lung epithelium
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.991120
- 2,121 views
- 5 citations
Case Report
Published on 27 Oct 2022
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.995744
- 4,489 views
- 11 citations
Case Report
Published on 27 Oct 2022
Significant response of pulmonary sarcomatoid carcinoma with obstructive atelectasis to treatment with the PD-1 inhibitor camrelizumab combined with transbronchial cryoablation: A case report and literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1013047
- 3,219 views
- 7 citations
Case Report
Published on 27 Oct 2022
Dramatic response to neoadjuvant savolitinib in marginally resectable lung adenocarcinoma with MET exon 14 skipping mutation: A case report and literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1006634
- 3,460 views
- 11 citations
Review
Published on 27 Oct 2022
MET-targeted therapies for the treatment of non-small-cell lung cancer: A systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1013299
- 9,349 views
- 14 citations